[Left ventricular hypertrophy in the cat - "when hypertrophic cardiomyopathy is not hypertrophic cardiomyopathy"]

T Glaus1, G Wess

  • 1Abteilung für Kardiologie, Klinik für Kleintiermedizin, Universität Zürich, Zürich. tglaus@vetclinics.uzh.ch

Insights

Hypertrophic cardiomyopathy (HCM) in cats can mimic other conditions. Differentiating primary HCM from secondary causes of left ventricular hypertrophy (LVH) requires careful clinical and echocardiographic evaluation over time.

Area of Science:

  • Veterinary Cardiology
  • Genetics
  • Cardiovascular Imaging

Context:

  • Hypertrophic cardiomyopathy (HCM) is a primary genetic condition.
  • Echocardiography defines HCM by left ventricular hypertrophy (LVH) without a clear secondary cause.
  • Distinguishing HCM from other causes of LVH in cats can be challenging.

Purpose:

  • To differentiate primary HCM from secondary causes of LVH in feline echocardiography.
  • To highlight conditions that mimic HCM, such as systemic hypertension, hyperthyroidism, and myocarditis.
  • To emphasize the importance of clinical course and serial echocardiography for accurate diagnosis.

Summary:

  • HCM is a primary genetic cardiomyopathy characterized by LVH.
  • Secondary causes of LVH, including systemic hypertension, hyperthyroidism, and myocarditis, can mimic HCM.
  • Hypovolemia may present as pseudohypertrophic changes.
  • Distinguishing HCM requires evaluating the clinical context and the echocardiographic progression over time, not just a single snapshot.

Impact:

  • Improved diagnostic accuracy for feline hypertrophic cardiomyopathy.
  • Enhanced understanding of differential diagnoses for LVH in cats.
  • Guidance for clinicians in differentiating primary HCM from secondary causes through serial assessments.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...